100 Million Covishield Doses Expired As People Are Not Getting Booster Dose: Serum Institute
indiatimes.com
news
2022-10-21 05:25:32

Serum Institute of India (SII), the manufacturer of the Oxford-Astrazeneca COVID-19 vaccine in India which is marketed as Covishiled has said that the company stopped its production in December 2021."Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100 million doses had already expired," SII CEO, Adar Poonawalla said. AFPNo takers for booster doseSpeaking on the sidelines of the annual general meeting of the developing countries Vaccine Manufacturers Network on Thursday in Pune, Poonawalla blamed it on the lack of demand as people were not keen on getting their booster dose of the COVID-19 vaccine.
